- Japan
- /
- Electronic Equipment and Components
- /
- TSE:7915
Nissha Third Quarter 2024 Earnings: Misses Expectations
Nissha (TSE:7915) Third Quarter 2024 Results
Key Financial Results
- Revenue: JP¥48.7b (up 19% from 3Q 2023).
- Net income: JP¥60.0m (up from JP¥225.0m loss in 3Q 2023).
- Profit margin: 0.1% (up from net loss in 3Q 2023).
- EPS: JP¥1.25 (up from JP¥4.61 loss in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Nissha Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) also missed analyst estimates by 96%.
Looking ahead, revenue is forecast to grow 4.2% p.a. on average during the next 3 years, compared to a 7.3% growth forecast for the Electronic industry in Japan.
Performance of the Japanese Electronic industry.
The company's shares are up 4.8% from a week ago.
Risk Analysis
You still need to take note of risks, for example - Nissha has 2 warning signs we think you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if Nissha might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:7915
Nissha
Engages in industrial materials, devices, medical technologies, information and communication, and pharmaceutical and cosmetics businesses in Japan and internationally.
Excellent balance sheet and fair value.